← Leaderboards
Bruce T. Shiramizu
University Of California San Francisco
$5,736,732
Attributed
$7,774,001
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2006–18$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$13,080,314 · 11
By mechanism
U54$5,306,313 · 1
R01$4,652,831 · 2
UG1$1,750,440 · 2
R21$1,319,880 · 4
M01$25,799 · 1
G12$25,051 · 1
Top collaborators
- Cecilia M Shikuma7 shared
- Thomas M Ernst2 shared
- Noreen Mokuau2 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Matthias R Wabl$7,929,531
- Katherine Kurshan Matthay$7,757,759
- Michael S German$33,618,125
- Clifford A Lowell$17,491,874
- John Kurhanewicz$27,913,734
Others in their field
Top investigators on “Macrophage”
- Craig B Thompson · Sloan-Kettering Inst Can Research$41,669,179
- Howard Eliot Gendelman · Children'S Memorial Hospital (Chicago)$41,668,744
- Selwyn M Vickers · University Of Alabama At Birmingham$40,969,055
- Alan A Aderem · University Of Washington$38,969,733
- Alan Richard Tall · Columbia University Health Sciences$38,053,695
- John S Condeelis · Yeshiva University$33,855,255
Research focus
MacrophageBrainPhenotypeCellsAids Dementia ComplexPathogenesisCd14 GeneMigrationLymphocyteVirusMonocyteAntiretroviral TherapyInnovationNeurocognitiveDiagnosisBaseHiv InfectionsImpaired CognitionNeuraxisNeuroimagingDesignBrain RegionCognitiveMagnetic Resonance Spectroscopy
Grant awards (31)
RCMI Multidisciplinary And Translational Research Infrastructure EXpansion (RAMAT$3,100,000
U54 · FY2018 · MD · contact PI
Maraviroc and NeuroAIDS Pathogenesis$628,325
R01 · FY2018 · MH · contact PI
RCMI Multidisciplinary And Translational Research Infrastructure EXpansion (RAMAT$2,206,313
U54 · FY2017 · MD · contact PI
Maraviroc and NeuroAIDS Pathogenesis$681,020
R01 · FY2017 · MH · contact PI
(PQ5) Informing anal neoplasia differences/similarities in HIV-serodiscordant individuals$231,000
R21 · FY2017 · CA · contact PI
Hawaii IDeA Center for Pediatric and Adolescent Clinical Trials (HIPACT)$1,657,240
UG1 · FY2016 · OD · contact PI
Maraviroc and NeuroAIDS Pathogenesis$645,027
R01 · FY2016 · MH
Maraviroc and NeuroAIDS Pathogenesis$141,735
R01 · FY2016 · MH
Hawaii IDeA Center for Pediatric and Adolescent Clinical Trials (HIPACT)$93,200
UG1 · FY2016 · HD · contact PI
Maraviroc and NeuroAIDS Pathogenesis$38,386
R01 · FY2016 · MH
Maraviroc and NeuroAIDS Pathogenesis$651,150
R01 · FY2015 · MH
Maraviroc and NeuroAIDS Pathogenesis$679,934
R01 · FY2014 · MH
Neuroimaging to Assess the Effects of Therapy in Children with Acute Lymphoblasti$304,481
R21 · FY2010 · CA · contact PI
HIV-1 Proviral DNA and Monocyte Phenotype in Relation to Neurocognitive Function$228,084
R01 · FY2010 · NS · contact PI
Neuroimaging to Assess the Effects of Therapy in Children with Acute Lymphoblasti$304,481
R21 · FY2009 · CA · contact PI
HIV-1 Proviral DNA and Monocyte Phenotype in Relation to Neurocognitive Function$230,388
R01 · FY2009 · NS · contact PI
HIV-1 Proviral DNA and Monocyte Phenotype in Relation to Neurocognitive Function$233,887
R01 · FY2008 · NS · contact PI
HIV-1 Proviral DNA and Monocyte Phenotype in Relation to Neurocognitive Function$19,603
R01 · FY2008 · NS · contact PI
HIV-1 Proviral DNA and Monocyte Phenotype in Relation to Neurocognitive Function$246,316
R01 · FY2007 · NS · contact PI
Real-time Minimal Residual Disease assay of Pediatric B-Cell Non-Hodgkin Lymphoma$102,134
R21 · FY2007 · CA · contact PI
HIV-1 Proviral DNA and Monocyte Phenotype in Relation to Neurocognitive Function$11,896
R01 · FY2007 · NS · contact PI
HIV-1 Proviral DNA and Monocyte Phenotype in Relation to Neurocognitive Function$217,080
R01 · FY2006 · NS · contact PI
Real-time Minimal Residual Disease assay of Pediatric B-Cell Non-Hodgkin Lymphoma$105,184
R21 · FY2006 · CA · contact PI
Activated Immune Parameters Associated with HIV &Aging$136,300
R21 · FY2004 · MH
A4: PROJ 1: ROLE OF MACROPHAGES IN HIV ASSOCIATED MALIGNANCIES$25,051
G12 · FY2004 · RR
Activated Immune Parameters Associated with HIV &Aging$136,300
R21 · FY2003 · MH
CLONAL MACROPHAGES IN CHILDREN WITH AIDS ASSOCIATED NEUROLOGIC DISEASE$0
M01 · FY2002 · RR
CLONAL MACROPHAGES IN CHILDREN WITH AIDS ASSOCIATED NEUROLOGIC DISEASE$0
M01 · FY2001 · RR
CLONAL MACROPHAGES IN CHILDREN WITH AIDS ASSOCIATED NEUROLOGIC DISEASE$25,799
M01 · FY2000 · RR
CLONAL MACROPHAGES IN CHILDREN WITH AIDS ASSOCIATED NEUROLOGIC DISEASE$0
M01 · FY2000 · RR
CLONAL MACROPHAGES IN CHILDREN WITH AIDS ASSOCIATED NEUROLOGIC DISEASE$0
M01 · FY2000 · RR